Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Leukemia 18Lymphoma 13Lymphoma, Extranodal NK-T-Cell 8Burkitt Lymphoma 8Recurrence 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm, Residual 3Dendritic Cell Sarcoma, Interdigitating 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Prolymphocytic 1Leukemia, Erythroblastic, Acute 1Hypersensitivity 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Ultrasonography 2Dexamethasone 2Calcium Dobesilate 2Blood Specimen Collection 2tislelizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1asparaginase erwinia chrysanthemi recombinant 1Vincristine 1Rituximab 1Narrow Band Imaging 1Methotrexate 1Mammography 1Immune Checkpoint Inhibitors 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Cytarabine 1Cetirizine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypersensitivity × Asparaginase × Clear all
NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
1 enrolled 7 charts
LymphoidOther hematologic neoplasm

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡